Zafiraki V K, Skaletsky K V, Kosmacheva E D, Shulzhenko L V, Ramazanov J M, Omarov A A
1Kuban State Medical University, Krasnodar, Russia; 2Central Hospital of Oilworkers, Baku, Azerbaijan; 3Scientific and Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Kardiologiia. 2016 Jan;56(1):51-55. doi: 10.18565/cardio.2016.1.51-55.
Currently enough data has been accumulated to consider chronic obstructive pulmonary disease (COPD) as one of important factors of poor prognosis in patients with coronary artery disease, possibly producing an impact on perioperative risk during coronary artery bypass grafting surgery and percutaneous coronary interventions, as well as on long-term outcomes of these procedures. In this review we have analyzed studies which attempted to assess COPD as a factor that can affect outcomes of myocardial revascularization.
目前已积累了足够的数据，足以将慢性阻塞性肺疾病（COPD）视为冠心病患者预后不良的重要因素之一，它可能会对冠状动脉搭桥手术和经皮冠状动脉介入治疗期间的围手术期风险以及这些手术的长期结果产生影响。在本综述中，我们分析了一些研究，这些研究试图评估COPD作为一种可影响心肌血运重建结果的因素。
